Antihypertensive drugs

AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1 / Akt2 / Akt3 and p70S6K / PKA with IC 50 s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.In VitroThe inhibition of AKT2 by AT7867 is shown to be ATP-competitive with a K i of

AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1 / Akt2 / Akt3 and p70S6K / PKA with IC 50 s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.In VitroThe inhibition of AKT2 by AT7867 is shown to be ATP-competitive with a K i of

AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1 / Akt2 / Akt3 and p70S6K / PKA with IC 50 s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.In VitroThe inhibition of AKT2 by AT7867 is shown to be ATP-competitive with a K i of

AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1 / Akt2 / Akt3 and p70S6K / PKA with IC 50 s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.In VitroThe inhibition of AKT2 by AT7867 is shown to be ATP-competitive with a K i of

AT7867 dihydrochloride is a potent ATP-competitive inhibitor of Akt1 / Akt2 / Akt3 and p70S6K / PKA with IC 50 s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.In VitroThe inhibition of AKT2 by AT7867 is shown to be ATP-competitive with a K i of

ATC 0175 hydrochloride.

ATC 0175 hydrochloride.

ATC 0175 hydrochloride.

Application Atenolol is a &#946-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Application Atenolol is a &#946-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Application Atenolol is a &#946-adrenergic blocker and used in the management of hypertension. Atenolol has antianginal and antiarrhythmic properties.

Atenolol, commonly sold under the trade name Tenormin &#174 , is a beta blocker used to treat a number of cardiac conditions from hypertension to angina. This Snap-N-Spike &#174 Reference Solution is suitable for use in atenolol methods by LC/MS